Japan · Biotechnology startup
Japan · Modalis Therapeutics
Modalis is a biotech company that develops therapeutics using CRISPR based technology.
Funding reportedLast round: Series B
What company datasets say Modalis Therapeutics raised
Funding, as reported
Reported in all38.5Min the source's currency
Rounds5
Last roundSeries B
Last round dateApr 2019
Investors listed14
Biotechnology in Japan
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Modalis Therapeutics in front of investors. Or tell us what we have wrong.